IP Verse

Process For The Manufacture Of Vortioxetine Hbr Alpha-Form

Patent No. EP3615518 (titled "Process For The Manufacture Of Vortioxetine Hbr Alpha-Form") was filed by H Lundbeck on Apr 20, 2018. The application was issued on Dec 15, 2021.

Patent Summary

A process for synthesizing a specific crystalline form of vortioxetine hydrobromide (α-form) used in pharmaceuticals. The process involves dissolving vortioxetine in highly pure toluene, followed by crystallization and drying steps. The resulting crystalline vortioxetine hydrobromide α-form can be used in pharmaceuticals to potentially improve factors like solubility and bioavailability.

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKSep 15, 2022ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3615518

H LUNDBECK
Application Number
EP18721975A
Filing Date
Apr 20, 2018
Status
Granted And Under Opposition
Nov 12, 2021
Publication Date
Dec 15, 2021
External Links
Slate, Register , Google Patents